|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Curis, Inc.
| | | Phone: | (617) 503-6500 | Fax: | (617) 503-6501 | Year Established: | 2000 | Ticker: | CRIS | Exchange: | NASDAQ | Main Contact: | Minji Kim, Ph.D., MBA, VP, Corporate & Business Development | | Other Contacts: | Robert Booher, Ph.D., Associate Director, Translational Sciences Lisa Massmanian, Director, Clinical Operations Frank Waligora, MBA, VP, Chemistry, Manufacturing and Controls Tim Wyant Ph.D., Senior Director, Cancer Immunology Tania Chander, Pharm.D., VP, Product Development David Tuck, M.D., Senior VP & CMO Mark Noel, VP, Technology Management & IP James Dentzer, CFO & CAO Ali Fattaey, Ph.D., President & CEO
| | Company Description | Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new medicines, primarily for cancer. In expanding its drug development efforts in the field of cancer through its targeted cancer drug development platform, Curis is building upon its previous experiences in targeting signaling pathways for the development of next generation targeted cancer therapies. | |
|
|
|
|
|